// App-Quantinova.ai

TCT-565 : NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clinical Results

Researchers

Presenter

  • Bo Xu

Principal Investigators

  • Kefei Dou

  • Yuejin Yang

  • Run-Lin Gao

  • Shuzheng Lu

  • Lefeng Wang

  • Haichang Wang

  • Zhanquan Li

  • Lei Wang

  • Yundai Chen

  • Yong Huo

  • Ajay Kirtane

Medical Centers

  • Affilaited Anzhen Hospital of Capital Medical University, Beijing, China

  • Affilaited Anzhen Hospital of Capital Medical University, Beijing, China

  • Peking University People's Hospital, Beijing, China

  • Fourth Military Medical University, Xi'an, China

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • Liaoning Provincial Tumor Hospital, Shenyang, China

  • Affilaited Anzhen Hospital of Capital Medical University, Beijing, China

  • Chinese PLA medical Univercity, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Coronary artery lesions

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved